Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory M Cole

Showing results (21-30 of 37) with videos related to

Pageof 4
Sort By:
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 25, 2015
Plasma BDNF levels associate with Pittsburgh compound B binding in the brainKristy S Hwang, Andreas S Lazaris, Jennifer A Eastman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisZezong Gu, Marcus Jackson, Tamanna Mony, et al.
Acta Neuropathologica|October 25, 2011
Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortexStephen Arold, Patrick Sullivan, Tina Bilousova, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
Serotonin 1A receptors in the living brain of Alzheimer's disease patientsVladimir Kepe, Jorge R Barrio, Sung-Cheng Huang, et al.
The Journal of Biological Chemistry|December 14, 2004
Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivoFusheng Yang, Giselle P Lim, Aynun N Begum, et al.
Neurobiology of Disease|September 16, 2015
Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerizationEdmond Teng, Karen Taylor, Tina Bilousova, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 25, 2009
Differential FDDNP PET patterns in nondemented middle-aged and older adultsLinda M Ercoli, Prabha Siddarth, Vladimir Kepe, et al.
The American Journal of Pathology|January 1, 2016
Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control CasesTina Bilousova, Carol A Miller, Wayne W Poon, et al.
Frontiers in Immunology|November 12, 2020
The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease ModelsQiu-Lan Ma, Cansheng Zhu, Marco Morselli, et al.
Dementia and Geriatric Cognitive Disorders|December 31, 2014
Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohortEdmond Teng, Nicole Chow, Kristy S Hwang, et al.
Pageof 4

Showing results (21-30 of 37) with videos related to

Sort By:
Pageof 4
Alzheimer'S & Dementia (Amsterdam, Netherlands)|July 25, 2015
Plasma BDNF levels associate with Pittsburgh compound B binding in the brainKristy S Hwang, Andreas S Lazaris, Jennifer A Eastman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Basic Science and PathogenesisZezong Gu, Marcus Jackson, Tamanna Mony, et al.
Acta Neuropathologica|October 25, 2011
Apolipoprotein E level and cholesterol are associated with reduced synaptic amyloid beta in Alzheimer's disease and apoE TR mouse cortexStephen Arold, Patrick Sullivan, Tina Bilousova, et al.
Proceedings of the National Academy of Sciences of the United States of America|January 13, 2006
Serotonin 1A receptors in the living brain of Alzheimer's disease patientsVladimir Kepe, Jorge R Barrio, Sung-Cheng Huang, et al.
The Journal of Biological Chemistry|December 14, 2004
Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivoFusheng Yang, Giselle P Lim, Aynun N Begum, et al.
Neurobiology of Disease|September 16, 2015
Dietary DHA supplementation in an APP/PS1 transgenic rat model of AD reduces behavioral and Aβ pathology and modulates Aβ oligomerizationEdmond Teng, Karen Taylor, Tina Bilousova, et al.
The American Journal of Geriatric Psychiatry : Official Journal of the American Association for Geriatric Psychiatry|April 25, 2009
Differential FDDNP PET patterns in nondemented middle-aged and older adultsLinda M Ercoli, Prabha Siddarth, Vladimir Kepe, et al.
The American Journal of Pathology|January 1, 2016
Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control CasesTina Bilousova, Carol A Miller, Wayne W Poon, et al.
Frontiers in Immunology|November 12, 2020
The Novel Omega-6 Fatty Acid Docosapentaenoic Acid Positively Modulates Brain Innate Immune Response for Resolving Neuroinflammation at Early and Late Stages of Humanized APOE-Based Alzheimer's Disease ModelsQiu-Lan Ma, Cansheng Zhu, Marco Morselli, et al.
Dementia and Geriatric Cognitive Disorders|December 31, 2014
Low plasma ApoE levels are associated with smaller hippocampal size in the Alzheimer's disease neuroimaging initiative cohortEdmond Teng, Nicole Chow, Kristy S Hwang, et al.
Pageof 4